{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:00:15Z","timestamp":1789390815042,"version":"build-2803163510"},"reference-count":15,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,2]]},"DOI":"10.1182\/blood-2016-11-752600","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T02:00:18Z","timestamp":1482890418000},"page":"1226-1227","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["ACE inhibitors and cytoreductive therapy in polycythemia vera"],"prefix":"10.1182","volume":"129","author":[{"given":"Tiziano","family":"Barbui","sequence":"first","affiliation":[{"name":"FROM Research Foundation, Papa Giovanni XIII Hospital, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Masciulli","sequence":"additional","affiliation":[{"name":"FROM Research Foundation, Papa Giovanni XIII Hospital, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Ghirardi","sequence":"additional","affiliation":[{"name":"FROM Research Foundation, Papa Giovanni XIII Hospital, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Carobbio","sequence":"additional","affiliation":[{"name":"FROM Research Foundation, Papa Giovanni XIII Hospital, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"19","key":"2019111903575718600_B1","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood-2014-07-591610","article-title":"In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology","volume":"124","author":"Barbui","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111903575718600_B2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111903575718600_B3","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111903575718600_B4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111903575718600_B5","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1002\/ajh.24583","article-title":"The effect of arterial hypertension on thrombosis in low-risk polycythemia vera","volume":"92","author":"Barbui","year":"2017","journal-title":"Am J Hematol"},{"issue":"4","key":"2019111903575718600_B6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2003.00850.x","article-title":"Posttransplant erythrocytosis","volume":"63","author":"Vlahakos","year":"2003","journal-title":"Kidney Int"},{"issue":"9","key":"2019111903575718600_B7","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1172\/JCI119769","article-title":"Angiotensin II stimulates proliferation of normal early erythroid progenitors","volume":"100","author":"Mrug","year":"1997","journal-title":"J Clin Invest"},{"issue":"suppl 3","key":"2019111903575718600_B8","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"issue":"11","key":"2019111903575718600_B9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/00007890-199806150-00009","article-title":"Use of aminophylline and enalapril in posttransplant polycythemia","volume":"65","author":"Mazzali","year":"1998","journal-title":"Transplantation"},{"issue":"1","key":"2019111903575718600_B10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/JDI-120017470","article-title":"A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis","volume":"25","author":"Trivedi","year":"2003","journal-title":"Ren Fail"},{"issue":"suppl 4","key":"2019111903575718600_B11","first-page":"49","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.3. Haematological complications. Erythrocytosis","volume":"17","author":"EBPG Expert Group on Renal Transplantation","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"9307","key":"2019111903575718600_B12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(02)07812-1","article-title":"Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial","volume":"359","author":"Plata","year":"2002","journal-title":"Lancet"},{"issue":"19","key":"2019111903575718600_B13","first-page":"4089","article-title":"Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies","volume":"20","author":"Haznedaroglu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2019111903575718600_B14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0609.1996.tb00503.x","article-title":"Polycythaemia vera: response to treatment with angiotensin-converting enzyme inhibitor","volume":"57","author":"Nomura","year":"1996","journal-title":"Eur J Haematol"},{"issue":"4","key":"2019111903575718600_B15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000065236","article-title":"IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria","volume":"22","author":"Chung","year":"2002","journal-title":"Am J Nephrol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/9\/1226\/1402159\/blood752600.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/9\/1226\/1402159\/blood752600.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T08:58:16Z","timestamp":1574153896000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/9\/1226\/36549\/ACE-inhibitors-and-cytoreductive-therapy-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-11-752600","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}